Literature DB >> 11488632

Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.

N Abiru1, L Yu, D Miao, A K Maniatis, E Liu, H Moriyama, G S Eisenbarth.   

Abstract

NOD mice spontaneously develop anti-insulin autoantibodies associated with the subsequent development of diabetes. NOD mice that express insulin autoantibodies at 8 weeks of age have a diabetes risk exceeding 90%, while mice that do not express autoantibodies by 16 weeks have a risk of less than 20%. NOD female mice expressed insulin autoantibodies more often than male mice (13/15+ vs. 6/15+). Autoantibodies characteristically developed between 8 and 20 weeks and then for most mice became negative at diabetes onset in NOD mice. In the diabetes-free strain NOR mice, spontaneous expression of insulin autoantibodies was observed in less mice (female 8/15+, male 3/10+) compared to NOD mice. The expression of autoantibodies was transient in NOR mice and followed the same time-course as for NOD mice and they were all negative by 28 weeks (without progression to diabetes). No correlation was found in NOR mice between the levels of autoantibodies and insulitis. The program of insulin autoantibody expression is regulated over approximately 5 months for both NOD and NOR mice with only NOD mice developing diabetes, indicating that depending upon genetic combination, the presence of insulin autoantibodies does not always predict diabetes development. In addition, this data is not consistent with the hypothesis that the time-course of autoantibodies simply reflects the destruction of beta-cells with development of diabetes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488632     DOI: 10.1006/jaut.2001.0530

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  14 in total

1.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

Authors:  Jacqueline D Trudeau; Carolyn Kelly-Smith; C Bruce Verchere; John F Elliott; Jan P Dutz; Diane T Finegood; Pere Santamaria; Rusung Tan
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.

Authors:  John C Hutton; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

Review 3.  Use of nonobese diabetic mice to understand human type 1 diabetes.

Authors:  Terri C Thayer; S Brian Wilson; Clayton E Mathews
Journal:  Endocrinol Metab Clin North Am       Date:  2010-07-08       Impact factor: 4.741

4.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

Review 5.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

6.  Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.

Authors:  Raymond J Steptoe; Janine M Ritchie; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic Mice.

Authors:  William M Hanes; Peder S Olofsson; Kevin Kwan; LaQueta K Hudson; Sangeeta S Chavan; Valentin A Pavlov; Kevin J Tracey
Journal:  Mol Med       Date:  2015-08-17       Impact factor: 6.354

8.  Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice.

Authors:  Roman Bashratyan; Huiming Sheng; Danielle Regn; M Jubayer Rahman; Yang D Dai
Journal:  Eur J Immunol       Date:  2013-08-01       Impact factor: 5.532

9.  Attacking the source: anti-PDX-1 responses in type 1 diabetes.

Authors:  Yaima Luzardo; Clayton Elwood Mathews
Journal:  Lab Invest       Date:  2010-01       Impact factor: 5.662

10.  Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model.

Authors:  John Virostko; Armandla Radhika; Greg Poffenberger; Adrienne N Dula; Daniel J Moore; Alvin C Powers
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.